Patents
Patents for C07C 323 - Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups (27,160)
01/2001
01/24/2001CN1281430A N-alkanoylphenylalanine derivatives
01/24/2001CN1061045C Process for preparation of new cephalosporins containing in position 7 substituted benzyloxyimino radical
01/23/2001USRE37029 Antipsychotic and analgesic agents
01/23/2001US6177592 Compounds
01/23/2001US6177551 Bridged aromatic substituted amine ligands with donor atoms
01/23/2001US6177469 Antiutor agents; autoimmune diseases
01/23/2001US6177463 Oxime derivatives and their use as pesticides
01/23/2001CA2191790C Biaromatic compounds containing an adamantyl group in para position; pharmaceutical and cosmetic compositions containing them and use thereof
01/23/2001CA2003172C Certain 2-(2',3',4'-trisubstituted benzoyl)-1,3-cyclohexanediones
01/22/2001CA2312203A1 Cyclobutene derivatives, their preparation and their therapeutic uses
01/18/2001WO2001004106A1 Process for producing dibenzothiazepine derivatives
01/18/2001WO2000063234A3 Pyrrolidincarbonylamino cyclic disulfides as vcam-vla4 antagonists
01/18/2001WO1999064049A9 Novel antibacterial agents
01/17/2001EP1068176A1 Cysteine amides as farnesyl transferase inhibitors
01/17/2001EP1040385A4 Thioglycerol derivatives and their use in polysulfide compositions for optical material
01/17/2001EP0983258A4 N-hydroxy 4-sulfonyl butanamide compounds
01/17/2001CN1280574A New heterocyclic compounds and their use in medicine, process for their prepartion and pharmaceutical compositions containing them
01/17/2001CN1280124A Serial 1-alkyl-1-alkoxy-1-alkylsulfonyl methane compounds and its preparing method
01/17/2001CN1060766C Technology for producing L-cystine by using sheeps' wool
01/16/2001US6175042 Process for preparing perfluoroalkyl aryl sulfides and novel perfluoroalkyl aryl sulfides
01/16/2001US6174964 Fluorochemical oligomer and use thereof
01/16/2001US6174924 Treating nerve cell death comprising administering to a subject exhibiting symptoms of nerve cell death or susceptible to nerve cell death a substituted guanidine compound
01/16/2001US6174887 Amide compounds and use of the same
01/16/2001US6174458 Tetracyclic compound having lateral halogen substituent and liquid crystal composition comprising the same
01/16/2001US6174455 Liquid crystalline compounds and process for producing the same
01/11/2001WO2001002344A1 Aminobenzoic acid derivatives
01/11/2001WO2001002032A1 Ophthalmic molding
01/11/2001WO2001001979A1 Therapeutic agents
01/11/2001CA2376553A1 Aminobenzoic acid derivatives
01/10/2001EP1067119A1 Method for isolation of n-protected s-phenylcysteine
01/10/2001EP1067109A1 Carboxylic acid derivatives and drugs containing the same as the active ingredient
01/10/2001EP1066258A1 Aryl phenyl substituted cyclic ketoenols
01/10/2001EP1066237A2 Processes for preparing intermediates
01/10/2001EP0855998B1 Antioxidants containing phenol groups and aromatic amine groups
01/10/2001CN1279775A Thioglycerol derivatives and their use in polysulfide compositions for optical material
01/09/2001US6172266 Triazole derivative or slat thereof, preparation process thereof and pharmaceutical containing said compound as an effective ingredient
01/09/2001US6172261 Biosynthesis using chain extension
01/09/2001US6172259 Resolution using phenylethylamine
01/09/2001US6172113 Bicyclic amino derivatives and PGD2 antagonist containing the same
01/09/2001US6172103 Treating bone disorders, osteoporosis, and arthritis
01/09/2001US6172082 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
01/09/2001US6172057 Antiinflammatory agents; antiarthritic agents; antitumor agents
01/09/2001CA2111854C Orally active antiviral compounds
01/04/2001WO2001000608A1 Process for the synthesis of n-(4-cyano-3-trifluoromethylphenyl)-3-(4-fluorophenylsulfonyl)-2-hydroxy-2-methylpropionamide
01/04/2001WO2001000579A1 COMPOUNDS FOR THE MODULATION OF PPARη ACTIVITY
01/04/2001WO2001000568A1 Hydrazone derivatives and pest controllers
01/04/2001WO2001000566A2 Substituted phenoxyacetic acids
01/04/2001CA2385798A1 Substituted phenoxyacetic acids
01/03/2001EP1064274A1 Benzenesulfonamide derivatives and their use as medicaments
01/03/2001EP1064271A1 2- (2-arylthioethyl)amino]-4-amino-1,3,5-triazines used as herbicides
01/03/2001EP1064259A1 New compounds
01/03/2001EP1064243A1 Coupling reactions with palladium catalysts
01/03/2001EP0811375B1 Glutamic acid receptor agonist
01/03/2001CN1278785A Vanadium complexes of monohydroxamates and pharmaceutical compositions comprising them
01/03/2001CN1060161C N-substituted phenylcarbamic acid derivatives, process for production thereof, agricultural and horticultural fungicides, intermediats of derlvatives and process for production thereof
01/03/2001CN1060160C Method for refining carbamates compound
01/03/2001CN1060159C Preparation for aromatic nitrile compound
01/02/2001US6169200 Alpha-acyloxy-thioesters useful enzyme inhibitors, such as hiv protease and renin
01/02/2001CA1341162C Sbustituted aminomethyltetralins and their heterocyclic analogues
12/2000
12/28/2000WO2000040593A3 Target molecule attachment to surfaces
12/27/2000EP1063241A1 Pharmaceutical preparations comprising thioctic acid or dihydrolipoic acid in the form of inclusion compounds with cyclodextrins oder cyclodextrin derivatives and in the form of granulates, chewing-or effervescent tablets
12/27/2000EP1062201A2 Halogenated amidino amino acid derivatives useful as nitric oxide synthase inhibitors
12/27/2000EP0716604A4 Thiol-derivatized nucleosides and oligonucleosides
12/27/2000CN1278255A Cyclopentene derivatives useful as antagonists of the motilin receptor
12/27/2000CN1278244A Dipeptide nitriles
12/26/2000US6166250 Continuous hydrolysis process for the preparation of 2-hydroxy-4-methylthiobutanoic acid
12/26/2000US6166086 Small molecules that increase the conversion of food to body weight gain
12/26/2000US6166075 A 3,4-diphenylbicyclo(4.3.0)nonyl compound
12/26/2000US6166072 Amino acid derivatives
12/26/2000US6166064 Antiinflammatory agents; antiarthritic agents
12/26/2000US6166057 Fungicides for the control of take-all disease of plants
12/26/2000US6166013 For modulating the glucocorticoid receptor in a mammal
12/21/2000WO2000077169A2 (z)-styryl acetoxyphenyl sulfides as cyclooxygenase inhibitors
12/21/2000WO2000076962A1 Thiol derivative, metallo-beta-lactamase inhibitors
12/21/2000WO2000047031A3 Chemical partitioning agents and methods of using same
12/21/2000WO2000044709A3 ACETYLENIC α-AMINO ACID-BASED SULFONAMIDE HYDROXAMIC ACID TACE INHIBITORS
12/21/2000CA2375511A1 (z)-styryl acetoxyphenyl sulfides as cyclooxygenase inhibitors
12/21/2000CA2374555A1 Thiol derivative, metallo-beta-lactamase inhibitors
12/20/2000EP1060739A1 Slimming cosmetic composition containing L-arginine or a derivative thereof
12/20/2000EP1060168A2 Method for preparing sulfanyl-type endothelin receptor antagonists
12/20/2000EP1059927A1 Chemical compounds and their use to elevate pyruvate dehydrogenase activity
12/20/2000EP1059919A1 Small molecules that increase the conversion of food to body weight gain
12/20/2000CN1277189A Aroma compound
12/20/2000CN1059677C Process for producing alpha-mercaptocarboxylic acid
12/19/2000US6162913 Preparation of [4S-(4α,7α,10aβ)]-4-amino-octahydro-5-oxo-7H-pyrido[2,1 -b] [1,3]thiazepine-7-carboxylic acid, methyl ester and salts thereof via novel disulfides
12/19/2000US6162841 Betaketosulphones derivatives suitable to the use as polymerization photoinitiators and photopolymerizable systems containing the same
12/19/2000US6162812 Pharmaceutical compositions containing HIV protease inhibitors and methods of their use
12/19/2000CA2202145C Enhanced solubilization of zinc and manganese methionine complex salts by addition of ferric ion
12/14/2000WO2000075105A1 Valency platform molecules comprising aminooxy groups
12/14/2000WO2000075101A1 Excitatory amino acid receptor modulators
12/14/2000WO2000074705A1 Rheumatic autoimmune disease antigen
12/14/2000CA2376057A1 Valency platform molecules comprising aminooxy groups
12/13/2000EP1059288A1 Process for the ring cleavage of thiazolidine derivatives
12/13/2000EP1059087A1 Antigens from rheumatoid autoimmune diseases
12/13/2000CN1276785A N-aroylphenylalanine derivs.
12/13/2000CN1059437C Method for preparation of cyanoimino-1,3-thiazolidine compounds
12/12/2000US6160167 Mercaptans and disulfides
12/12/2000US6160132 Chemical intermediate for matrix metalloproteinase (mmp) inhibitor formed by cyclization and iodination of an unsaturated acid/amide and then replacing iodine group with mercaptan or protected sulfur group
12/12/2000US6160011 Non-steroidal agonist compounds and their use in male hormone therapy
12/12/2000US6159995 Substituted diaminocarboxylic acids